Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic Cancer
Pancreatic ductal adenocarcinoma is one of the most aggressive forms of cancer, and the third leading cause of cancer-related mortality in the United States. Although important advances have been made in the last decade, the mortality rate of pancreatic ductal adenocarcinoma has not changed apprecia...
Main Authors: | Leticia Moreira, Basil Bakir, Priya Chatterji, Zahra Dantes, Maximilian Reichert, Anil K. Rustgi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | Cellular and Molecular Gastroenterology and Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352345X17301832 |
Similar Items
-
A pancreas tumor derived organoid study: from drug screen to precision medicine
by: Jia Yao, et al.
Published: (2021-07-01) -
Diagnóstico, estadiamento e tratamento cirúrgico do adenocarcinoma de pâncreas Diagnosis, staging and treatment of pancreatic adenocarcinoma
by: Enio Campos Amico, et al.
Published: (2008-12-01) -
Long-term expansion, genomic stability and in vivo safety of adult human pancreas organoids
by: Nikitas Georgakopoulos, et al.
Published: (2020-02-01) -
The challenge of developing human 3D organoids into medicines
by: Joaquim Vives, et al.
Published: (2020-03-01) -
Cáncer de páncreas en edad pediátrica
by: Ricardo Andrés Gamarra Samaniego, et al.